Indeed, our RA patients during the SARS-CoV-2 infection were receiving csDMARDs (HCQ and MTX), while three of them were receiving also TNFa inhibitors, and one patient was on treatment with an IL-6 receptor antagonist. Here, TNF is linked to rheumatoid arthritis.